## Abstract The original article to which this Erratum refers was published in Cancer (2003) 98(3) 632β44.
Nicotine dependence treatment for patients with cancer : Review and recommendations
β Scribed by Lisa Sanderson Cox; Nicole L. Africano; Kenneth P. Tercyak; Kathryn L. Taylor
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 119 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND
Cancer patients who use tobacco demonstrate characteristics of strong nicotine dependence and are at increased risk for future tobaccoβrelated morbidity and mortality. Continued smoking may contribute to poorer cancer treatment outcome and additional illness. In contrast, stopping smoking may improve quality of life and facilitate cancer treatment. Unfortunately, limited attention has been given to addressing tobacco use and treating nicotine dependence in cancer patients.
METHODS
The authors reviewed the current literature on smoking cessation and nicotine dependence treatment in patients with cancer.
RESULTS
Nicotine dependence treatment in patients with cancer facilitates smoking cessation. Evidence that cancer patients are motivated and able to stop smoking support tobacco use treatment intervention. Research is needed to evaluate effective intervention to aid tobacco abstinence and evaluate related health benefits for this patient population.
CONCLUSIONS
Cancer patients are able to stop smoking and benefit from intervention. Treatment of nicotine dependence in cancer patients merits attention from researchers and healthcare providers. The health risks of continued smoking and clear benefits of tobacco abstinence provide an ethical imperative for treating nicotine dependence in cancer patients. Research is needed to evaluate effective intervention with the overall goal of promoting tobacco abstinence to benefit oncology treatment and patient health. Cancer 2003;98:632β44. Β© 2003 American Cancer Society.
DOI 10.1002/cncr.11538
π SIMILAR VOLUMES
## Abstract Evidenceβbased medicine integrates the best available data in decision making, with the goal of minimizing physicians' and patients' subjectivity. In 2006, the American Society of Clinical Oncology edited clinical practice guidelines for the use of larynx preservation strategies. The ob
Background Although several approaches have been attempted for cocaine dependence, the pharmacological treatment of this serious disorder remains unclear. To date, desipramine, a tricyclic antidepressant of great noradrenergic activity, has shown the best results. Reboxetine, a selective noradrenali
## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of lowβ molecularβweight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology
## Abstract ## BACKGROUND The current study described tobacco use outcomes among patients with head and neck carcinoma who underwent treatment for nicotine dependence at the Mayo Clinic Nicotine Dependence Center (NDC; Rochester, MN). ## METHODS Using a 1:1 matchedβpair design, conditional logis